Effect of intra-dialytic neuromuscular electrical stimulation and oral nutritional supplements in hemodialysis patients, a randomized-controlled trial

ational Medical Center0 个研究点目标入组 72 人开始时间: 待定最近更新: 2022年10月24日

适应症

试验速览

暂无简介。

•Stable patients with end-stage renal disease undergoing dialysis for more than 3 months
•-Patients suspected of protein energy wasting with serum albumin <4.0 g/dL
•-Patients who can understand the study

•-Acute kidney injury
•-Patients with uncontrolled hypertension, diabetes, or heart failure
•-Patients with AST(GOT) or ALT(GPT) 3 times or more than the upper normal limit of the test institution
•-Patients diagnosed with hematologic or solid cancer undergoing treatment
•-Patients with active infection
•-HIV positive patients
•-Patients with a history of ischemic heart disease, stroke, deep vein thrombosis within 3 months
•-Patients planning a kidney transplantation within 3 months
•-Patients with limited electrical stimulation, such as implantable cardioverter-defibrillators
•-Patients with skin lesions at the electrical stimulation site
•-Patients allergic to protein supplements
•-Patients who have participated in other clinical trials within 2 months of the start of this clinical trial or plan to participate in other clinical trials during this human application trial period
•-Pregnant woman
•-Patients who judge that the investigator is inappropriate for participating in this clinical trial, such as poor understanding of this clinical trial due to old age, etc.

发起方

ational Medical Center